David Salzman
Chief Executive Officer Gatehouse Bio
Seminars
Thursday 20th August 2026
AI-Driven microRNA Target Discovery for CNS: Unlocking Precision Oligonucleotide Therapeutics
4:00 pm
- Leveraging large-scale, translational multi-omics datasets to identify novel microRNA isomiRs associated with CNS disease biology and progression
- Applying AI-driven modelling to stratify patients and uncover precision oligo targets linked to distinct disease trajectories
- Enabling end-to-end translation from human data to preclinical models, supporting target validation, biomarker development, and therapeutic discovery
